Affiliation:
1. Biostatistics Department 89bio, Inc. San Francisco California USA
2. Department of Mathematics, Statistics, and Computer Science University of Illinois at Chicago Chicago Illinois
Abstract
The statistical methodology for model‐based dose finding under model uncertainty has attracted increasing attention in recent years. While the underlying principles are simple and easy to understand, developing and implementing an efficient approach for binary responses can be a formidable task in practice. Motivated by the statistical challenges encountered in a phase II dose finding study, we explore several key design and analysis issues related to the hybrid testing‐modeling approaches for binary responses. The issues include candidate model selection and specifications, optimal design and efficient sample size allocations, and, notably, the methods for dose‐response testing and estimation. Specifically, we consider a class of generalized linear models suited for the candidate set and establish D‐optimal designs for these models. Additionally, we propose using permutation‐based tests for dose‐response testing to avoid asymptotic normality assumptions typically required for contrast‐based tests. We perform trial simulations to enhance our understanding of these issues.
Reference19 articles.
1. Combining Multiple Comparisons and Modeling Techniques in Dose-Response Studies
2. Model-based dose finding under model uncertainty using general parametric models
3. EMA.Qualification opinion of MCP‐Mod as an efficient statistical methodology for model‐based design and analysis of phase‐II dose finding studies under model uncertainty.https://www.ema.europa.eu/en/human‐regulatory‐overview/research‐and‐development/scientific‐advice‐and‐protocol‐assistance/opinions‐and‐letters‐support‐qualification‐novel‐methodologies‐medicine‐development2014.
4. FDA.Drug Development Tools: Fit‐for‐Purpose Initiative on MCP‐Mod.https://www.fda.gov/drugs/development‐approval‐process‐drugs/drug‐development‐tools‐fit‐purpose‐initiative2016.
5. Optimal Designs for Dose-Finding Studies